Sageworth Trust’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-328
Closed -$26.4K – 283
2023
Q1
$26.4K Buy
+328
New +$26.7K ﹤0.01% 184
2022
Q2
– Sell
-75
Closed -$8K – 415
2022
Q1
$8K Sell
75
-75
-50% -$7.92K ﹤0.01% 203
2021
Q4
$16K Sell
150
-188
-56% -$21.8K ﹤0.01% 210
2021
Q3
$42K Sell
338
-2,218
-87% -$287K ﹤0.01% 208
2021
Q2
$317K Buy
2,556
+2,406
+1,604% +$302K 0.03% 88
2021
Q1
$18K Sell
150
-248
-62% -$29.1K ﹤0.01% 235
2020
Q4
$47K Buy
398
+248
+165% +$27.3K ﹤0.01% 121
2020
Q3
$16K Buy
150
+142
+1,775% +$14.3K ﹤0.01% 125
2020
Q2
$1K Buy
+8
New +$767 ﹤0.01% 196
2019
Q1
– Sell
-6
Closed -$1K – 284
2018
Q4
$1K Buy
+6
New +$561 ﹤0.01% 149
2018
Q2
– Sell
-99
Closed -$8K – 179
2018
Q1
$8K Buy
+99
New +$8.17K ﹤0.01% 106

Other funds holding MDT

Sageworth Trust's MDT Position: Q2 2023 in Review

Sageworth Trust sold out of Medtronic (MDT) in Q2 2023, closing a stake of 328 shares — an estimated $26.4K sold.

Sageworth Trust first reported a position in MDT in Q1 2018 and held it in 11 quarters. The position peaked at $317K in Q2 2021. 2,056 funds tracked by Wall St. Rank hold MDT as of Q2 2023.

  • Sageworth Trust reported no remaining Medtronic position as of Q2 2023 after selling out during the quarter.
  • Sageworth Trust sold 328 Medtronic shares in Q2 2023, an estimated $26.4K.
  • Sageworth Trust first reported a position in Medtronic in Q1 2018 and held it in 11 quarters.
  • Sageworth Trust's Medtronic position peaked at $317K in Q2 2021.
  • 2,056 funds tracked by Wall St. Rank held Medtronic as of Q2 2023.

Based on Sageworth Trust's 13F filing for Q2 2023, filed 26 Jul 2023.